Multinational Medicines — Ensuring Drug Quality in an Era of Global Manufacturing  

Oleh:

Okie, Susan

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: The New England Journal of Medicine (keterangan: ada di Proquest) vol. 361 no. 08 (Aug. 2009), page 737-740 .

Ketersediaan

Perpustakaan FK Nomor Panggil: N08.K.2009.04 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Rickee Rudowitz, a 56-year-old New Jersey woman with hypertension, believes that a generic version of long-acting metoprolol played havoc with her health last year. Rudowitz said her blood pressure had been well controlled for 3 years by Toprol XL, AstraZeneca's brand-name beta-blocker, but that it "went over the moon" when her pharmacy-benefits program switched her to a generic version in early 2008. "I started having headaches and a lot of shortness of breath," she recalled. Her doctor switched her back to the brand-name drug, she said, and her symptoms disappeared.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali